Nicotinic acetylcholine receptors in chemotherapeutic drugs resistance: An emerging targeting candidate

Nicotinic acetylcholine receptors in chemotherapeutic drugs resistance: An emerging targeting candidate


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: خلیل حاجی اصغرزاده , زهرا اسدزاده , نادیا بلندی , بهزاد برادران , مینا افراشته نور

کلمات کلیدی: Nicotinic acetylcholine receptors; Chemotherapy; Apoptosis; Chemoresistance

نشریه: 22959 , 2021 , 278 , 2021

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله بهزاد برادران
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات ایمونولوژی
کد مقاله 76364
عنوان فارسی مقاله Nicotinic acetylcholine receptors in chemotherapeutic drugs resistance: An emerging targeting candidate
عنوان لاتین مقاله Nicotinic acetylcholine receptors in chemotherapeutic drugs resistance: An emerging targeting candidate
ناشر 6
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ خیر
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Review Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Abstract There is no definitive cure for cancer, and most of the current chemotherapy drugs have limited effects due to the development of drug resistance and toxicity at high doses. Therefore, there is an ongoing need for identifying the causes of chemotherapeutic resistance, and it will be possible to develop innovative treatment approaches based on these novel targeting candidates. Cigarette smoking is known to be one of the main causes of resistance to chemotherapeutic agents. Nicotine as a component of cigarette smoke is an exogenous activator of nicotinic acetylcholine receptors (nAChRs). It can inhibit apoptosis, increase cell proliferation and cell survival, reducing the cytotoxic effects of chemotherapy drugs and cause a reduced therapeutic response. Recent studies have demonstrated that nAChRs and their downstream signaling pathways have considerable implications in different cancer's initiation, progression, and chemoresistance. In some previous studies, nAChRs have been targeted to obtain better efficacies for chemotherapeutics. Besides, nAChRs-based therapies have been used in combination with chemotherapy drugs to reduce the side effects. This strategy requires lower doses of chemotherapy drugs compared to the conditions that must be used alone. Here, we discussed the experimental and clinical studies that show the nAChRs involvement in response to chemotherapy agents. Also, controversies relating to the effects of nAChR on chemotherapy-induced apoptosis are in our focus in this review article. Delineating the complex influences of nAChRs would be of great interest in establishing new effective chemotherapy regimens.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
خلیل حاجی اصغرزادهدوم
زهرا اسدزادهسوم
نادیا بلندیپنجم
بهزاد برادرانششم
مینا افراشته نوراول

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
523-Nicotinic acetylcholine receptors in chemotherapeutic drugs (2).pdf1400/07/103925793دانلود